GENOMIC HEALTH INC Insider Trading for January 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENOMIC HEALTH INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GENOMIC HEALTH INC for January 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Option Exercise | A | 72.52 | 27,740 | 2,011,705 | 27,740 | |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Grant | A | 0.00 | 4,020 | 0 | 48,067 | 44 K to 48.1 K (+9.13 %) |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | McEachron Kim | Chief People Office ... | Option Exercise | A | 72.52 | 9,530 | 691,116 | 9,530 | |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | McEachron Kim | Chief People Office ... | Grant | A | 0.00 | 4,140 | 0 | 38,566 | 34.4 K to 38.6 K (+12.03 %) |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Option Exercise | A | 72.52 | 8,100 | 587,412 | 8,100 | |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Grant | A | 0.00 | 3,520 | 0 | 20,849 | 17.3 K to 20.8 K (+20.31 %) |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Pla Frederic | COO | Option Exercise | A | 72.52 | 28,570 | 2,071,896 | 28,570 | |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Pla Frederic | COO | Grant | A | 0.00 | 4,140 | 0 | 39,678 | 35.5 K to 39.7 K (+11.65 %) |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | A | 72.52 | 75,610 | 5,483,237 | 75,610 | |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Grant | A | 0.00 | 10,960 | 0 | 68,028 | 57.1 K to 68 K (+19.21 %) |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Radford Jason W. | Chief Legal Officer | Option Exercise | A | 72.52 | 16,270 | 1,179,900 | 16,270 | |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Radford Jason W. | Chief Legal Officer | Grant | A | 0.00 | 7,070 | 0 | 38,396 | 31.3 K to 38.4 K (+22.57 %) |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | A | 72.52 | 9,530 | 691,116 | 9,530 | |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Grant | A | 0.00 | 4,140 | 0 | 24,125 | 20 K to 24.1 K (+20.72 %) |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | A | 72.52 | 20,180 | 1,463,454 | 20,180 | |
| Jan 31 2019 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Grant | A | 0.00 | 2,930 | 0 | 339,671 | 336.7 K to 339.7 K (+0.87 %) |
| Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.55 | 13,634 | 961,887 | 9,092,565 | 9.1 M to 9.1 M (-0.15 %) |
| Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.55 | 2,093 | 147,662 | 1,430,453 | 1.4 M to 1.4 M (-0.15 %) |
| Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.55 | 361 | 25,469 | 280,280 | 280.6 K to 280.3 K (-0.13 %) |
| Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.55 | 210 | 14,816 | 179,656 | 179.9 K to 179.7 K (-0.12 %) |
| Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.55 | 16 | 1,129 | 51,304 | 51.3 K to 51.3 K (-0.03 %) |
| Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.55 | 234 | 16,509 | 195,845 | 196.1 K to 195.8 K (-0.12 %) |
| Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.35 | 24,660 | 1,759,553 | 9,106,199 | 9.1 M to 9.1 M (-0.27 %) |
| Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.35 | 3,786 | 270,141 | 1,432,546 | 1.4 M to 1.4 M (-0.26 %) |
| Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.35 | 653 | 46,593 | 280,641 | 281.3 K to 280.6 K (-0.23 %) |
| Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.35 | 378 | 26,971 | 179,866 | 180.2 K to 179.9 K (-0.21 %) |
| Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.35 | 29 | 2,069 | 51,320 | 51.3 K to 51.3 K (-0.06 %) |
| Jan 30 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.35 | 423 | 30,182 | 196,079 | 196.5 K to 196.1 K (-0.22 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.20 | 75,736 | 5,468,397 | 9,130,859 | 9.2 M to 9.1 M (-0.82 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.20 | 11,627 | 839,509 | 1,436,332 | 1.4 M to 1.4 M (-0.80 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.20 | 2,004 | 144,696 | 281,294 | 283.3 K to 281.3 K (-0.71 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.20 | 1,162 | 83,900 | 180,244 | 181.4 K to 180.2 K (-0.64 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.20 | 89 | 6,426 | 51,349 | 51.4 K to 51.3 K (-0.17 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.20 | 1,298 | 93,720 | 196,502 | 197.8 K to 196.5 K (-0.66 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.02 | 65,426 | 4,711,967 | 9,206,595 | 9.3 M to 9.2 M (-0.71 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.02 | 10,044 | 723,367 | 1,447,959 | 1.5 M to 1.4 M (-0.69 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.02 | 1,732 | 124,738 | 283,298 | 285 K to 283.3 K (-0.61 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.02 | 1,004 | 72,308 | 181,406 | 182.4 K to 181.4 K (-0.55 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.02 | 76 | 5,474 | 51,438 | 51.5 K to 51.4 K (-0.15 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.02 | 1,121 | 80,734 | 197,800 | 198.9 K to 197.8 K (-0.56 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.46 | 1,648 | 121,054 | 9,272,021 | 9.3 M to 9.3 M (-0.02 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.46 | 253 | 18,584 | 1,458,003 | 1.5 M to 1.5 M (-0.02 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.46 | 44 | 3,232 | 285,030 | 285.1 K to 285 K (-0.02 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.46 | 25 | 1,836 | 182,410 | 182.4 K to 182.4 K (-0.01 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.46 | 2 | 147 | 51,514 | 51.5 K to 51.5 K (0.00 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.46 | 28 | 2,057 | 198,921 | 198.9 K to 198.9 K (-0.01 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.52 | 29,260 | 2,063,313 | 9,273,669 | 9.3 M to 9.3 M (-0.31 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.52 | 4,492 | 316,760 | 1,458,256 | 1.5 M to 1.5 M (-0.31 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.52 | 774 | 54,580 | 285,074 | 285.8 K to 285.1 K (-0.27 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.52 | 450 | 31,732 | 182,435 | 182.9 K to 182.4 K (-0.25 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.52 | 34 | 2,398 | 51,516 | 51.6 K to 51.5 K (-0.07 %) |
| Jan 25 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.52 | 502 | 35,399 | 198,949 | 199.5 K to 198.9 K (-0.25 %) |
| Jan 24 2019 | GHDX | GENOMIC HEALTH INC | Radford Jason W. | Chief Legal Officer | Sell | S | 71.95 | 1,425 | 102,529 | 31,326 | 32.8 K to 31.3 K (-4.35 %) |
| Jan 24 2019 | GHDX | GENOMIC HEALTH INC | Radford Jason W. | Chief Legal Officer | Sell | S | 70.97 | 1,538 | 109,154 | 32,751 | 34.3 K to 32.8 K (-4.49 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 27.00 | 1,285 | 34,695 | 23,138 | |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 27.00 | 1,285 | 34,695 | 23,138 | |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 31.12 | 937 | 29,159 | 29,835 | |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 31.12 | 937 | 29,159 | 29,835 | |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 27.00 | 1,285 | 34,695 | 19,985 | 18.7 K to 20 K (+6.87 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 27.00 | 1,285 | 34,695 | 19,985 | 18.7 K to 20 K (+6.87 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 31.12 | 937 | 29,159 | 18,700 | 17.8 K to 18.7 K (+5.28 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 31.12 | 937 | 29,159 | 18,700 | 17.8 K to 18.7 K (+5.28 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.00 | 42,521 | 3,018,995 | 9,302,929 | 9.3 M to 9.3 M (-0.45 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.00 | 6,529 | 463,560 | 1,462,748 | 1.5 M to 1.5 M (-0.44 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.00 | 1,125 | 79,875 | 285,848 | 287 K to 285.8 K (-0.39 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.00 | 652 | 46,292 | 182,885 | 183.5 K to 182.9 K (-0.36 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.00 | 50 | 3,550 | 51,550 | 51.6 K to 51.6 K (-0.10 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.00 | 729 | 51,759 | 199,451 | 200.2 K to 199.5 K (-0.36 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.61 | 10,547 | 755,298 | 9,345,450 | 9.4 M to 9.3 M (-0.11 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.61 | 1,619 | 115,941 | 1,469,277 | 1.5 M to 1.5 M (-0.11 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.61 | 279 | 19,980 | 286,973 | 287.3 K to 287 K (-0.10 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.61 | 162 | 11,601 | 183,537 | 183.7 K to 183.5 K (-0.09 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.61 | 12 | 859 | 51,600 | 51.6 K to 51.6 K (-0.02 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 71.61 | 181 | 12,962 | 200,180 | 200.4 K to 200.2 K (-0.09 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.23 | 13,595 | 981,964 | 9,355,997 | 9.4 M to 9.4 M (-0.15 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.23 | 2,087 | 150,744 | 1,470,896 | 1.5 M to 1.5 M (-0.14 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.23 | 360 | 26,003 | 287,252 | 287.6 K to 287.3 K (-0.13 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.23 | 209 | 15,096 | 183,699 | 183.9 K to 183.7 K (-0.11 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.23 | 16 | 1,156 | 51,612 | 51.6 K to 51.6 K (-0.03 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.23 | 233 | 16,830 | 200,361 | 200.6 K to 200.4 K (-0.12 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.79 | 132,363 | 9,634,226 | 9,369,592 | 9.5 M to 9.4 M (-1.39 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.79 | 20,322 | 1,479,165 | 1,472,983 | 1.5 M to 1.5 M (-1.36 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.79 | 3,503 | 254,971 | 287,612 | 291.1 K to 287.6 K (-1.20 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.79 | 2,031 | 147,829 | 183,908 | 185.9 K to 183.9 K (-1.09 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.79 | 155 | 11,282 | 51,628 | 51.8 K to 51.6 K (-0.30 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 72.79 | 2,268 | 165,080 | 200,594 | 202.9 K to 200.6 K (-1.12 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.79 | 149,754 | 10,601,295 | 9,501,955 | 9.7 M to 9.5 M (-1.55 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.79 | 22,991 | 1,627,565 | 1,493,305 | 1.5 M to 1.5 M (-1.52 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.79 | 3,963 | 280,546 | 291,115 | 295.1 K to 291.1 K (-1.34 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.79 | 2,298 | 162,679 | 185,939 | 188.2 K to 185.9 K (-1.22 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.79 | 175 | 12,388 | 51,783 | 52 K to 51.8 K (-0.34 %) |
| Jan 22 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.79 | 2,566 | 181,651 | 202,862 | 205.4 K to 202.9 K (-1.25 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.07 | 493 | 34,545 | 9,651,709 | 9.7 M to 9.7 M (-0.01 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.07 | 76 | 5,325 | 1,516,296 | 1.5 M to 1.5 M (-0.01 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.07 | 13 | 911 | 295,078 | 295.1 K to 295.1 K (0.00 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.07 | 8 | 561 | 188,237 | 188.2 K to 188.2 K (0.00 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.07 | 1 | 70 | 51,958 | 52 K to 52 K (0.00 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.07 | 9 | 631 | 205,428 | 205.4 K to 205.4 K (0.00 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.22 | 23,462 | 1,647,574 | 9,652,202 | 9.7 M to 9.7 M (-0.24 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.22 | 3,602 | 252,944 | 1,516,372 | 1.5 M to 1.5 M (-0.24 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.22 | 621 | 43,609 | 295,091 | 295.7 K to 295.1 K (-0.21 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.22 | 360 | 25,280 | 188,245 | 188.6 K to 188.2 K (-0.19 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.22 | 27 | 1,896 | 51,959 | 52 K to 52 K (-0.05 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.22 | 402 | 28,230 | 205,437 | 205.8 K to 205.4 K (-0.20 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.28 | 8,392 | 589,772 | 9,675,664 | 9.7 M to 9.7 M (-0.09 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.28 | 1,288 | 90,518 | 1,519,974 | 1.5 M to 1.5 M (-0.08 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.28 | 222 | 15,602 | 295,712 | 295.9 K to 295.7 K (-0.08 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.28 | 129 | 9,066 | 188,605 | 188.7 K to 188.6 K (-0.07 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.28 | 10 | 703 | 51,986 | 52 K to 52 K (-0.02 %) |
| Jan 14 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 70.28 | 144 | 10,120 | 205,839 | 206 K to 205.8 K (-0.07 %) |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Option Exercise | M | 22.98 | 10,000 | 229,800 | 36,424 | |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Option Exercise | M | 17.18 | 5,000 | 85,900 | 31,471 | |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 67.85 | 4,472 | 303,413 | 44,047 | 48.5 K to 44 K (-9.22 %) |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 66.67 | 3,428 | 228,528 | 48,519 | 51.9 K to 48.5 K (-6.60 %) |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 65.87 | 2,100 | 138,330 | 51,947 | 54 K to 51.9 K (-3.89 %) |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Buy | M | 22.98 | 10,000 | 229,800 | 54,047 | 44 K to 54 K (+22.70 %) |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 67.86 | 2,200 | 149,290 | 44,047 | 46.2 K to 44 K (-4.76 %) |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 66.68 | 1,700 | 113,355 | 46,247 | 47.9 K to 46.2 K (-3.55 %) |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 65.90 | 1,100 | 72,485 | 47,947 | 49 K to 47.9 K (-2.24 %) |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Buy | M | 17.18 | 5,000 | 85,900 | 49,047 | 44 K to 49 K (+11.35 %) |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 31.12 | 3,000 | 93,360 | 30,772 | |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 67.95 | 1,200 | 81,542 | 17,763 | 19 K to 17.8 K (-6.33 %) |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 66.82 | 1,000 | 66,819 | 18,963 | 20 K to 19 K (-5.01 %) |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 66.03 | 800 | 52,820 | 19,963 | 20.8 K to 20 K (-3.85 %) |
| Jan 09 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 31.12 | 3,000 | 93,360 | 20,763 | 17.8 K to 20.8 K (+16.89 %) |
| Jan 03 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 64.41 | 155 | 9,984 | 67,619 | 67.5 K to 67.6 K (+0.23 %) |
| Jan 03 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Grant | A | 64.41 | 155 | 9,984 | 6,332 | 6.2 K to 6.3 K (+2.51 %) |
| Jan 03 2019 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Grant | A | 64.41 | 155 | 9,984 | 51,803 | 51.6 K to 51.8 K (+0.30 %) |